Ocular Hypertension
Showing NaN - NaN of 32
Open Angle Glaucoma, Ocular Hypertension Trial in United States (Travoprost, Placebo Vehicle)
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- Travoprost
- Placebo Vehicle
-
Artesia, California
- +9 more
Sep 14, 2021
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
- PF-04217329 - Lowest Dose
- +8 more
-
Artesia, California
- +22 more
Apr 6, 2021
Open Angle Glaucoma, Ocular Hypertension Trial in United States (Xalacom, Xalatan, Timolol)
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- Xalacom
- +2 more
-
Birmingham, Alabama
- +63 more
Feb 17, 2021
Open Angle Glaucoma, Ocular Hypertension Trial in Worldwide (1 drop of 0.375% SYL040012 (bamosiran), 1 drop of 0.750% SYL040012
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- 1 drop of 0.375% SYL040012 (bamosiran)
- +4 more
-
Artesia, California
- +20 more
Dec 11, 2020
Glaucoma, Ocular Hypertension Trial in United States (RKI983A, Latanoprost)
Completed
- Glaucoma
- Ocular Hypertension
-
Artesia, California
- +28 more
Dec 11, 2020
Primary Open Angle Glaucoma, Ocular Hypertension, Pigmentary Glaucoma Trial in United States (PF-03187207 and Latanoprost
Completed
- Primary Open Angle Glaucoma
- +3 more
- PF-03187207 and Latanoprost Vehicle
- Latanoprost 0.005% and PF-03187207 Vehicle
-
Artesia, California
- +18 more
Sep 10, 2020
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Ocular Insert)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
- Bimatoprost
- +3 more
-
Fayetteville, Arkansas
- +9 more
May 18, 2020
Glaucoma, Open-angle, Ocular Hypertension Trial in United States (0.01% RO7058584, 0.1% RO7058584, 1% RO7058584)
Completed
- Glaucoma, Open-angle
- Ocular Hypertension
- 0.01% RO7058584
- +4 more
-
Chandler, Arizona
- +7 more
Mar 27, 2020
Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (bimatoprost 20 µg generation 2, bimatoprost 15 µg generation 2,
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
- bimatoprost 20 µg generation 2
- +6 more
-
Artesia, California
- +56 more
Mar 27, 2020
Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG324 Ophthalmic Solution 0.01%, PG324 Ophthalmic Solution
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- PG324 Ophthalmic Solution 0.01%
- +3 more
-
Artesia, California
- +22 more
May 14, 2019
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
-
Fayetteville, Arkansas
- +8 more
Mar 26, 2019
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
-
Artesia, California
- +9 more
Feb 1, 2019
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Eye Drops)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
- Bimatoprost
- +3 more
-
Artesia, California
- +9 more
Mar 22, 2018
Open-angle Glaucoma, Ocular Hypertension Trial in United States (DE-117 Low Dose ophthalmic solution, DE-117 Low/Middle Dose
Completed
- Open-angle Glaucoma
- Ocular Hypertension
- DE-117 Low Dose ophthalmic solution
- +5 more
-
Chandler, Arizona
- +13 more
Apr 16, 2018
Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic
Completed
- Ocular Hypertension
- Open Angle Glaucoma
- AR-13324 Ophthalmic Solution 0.01%
- +2 more
-
Artesia, California
- +21 more
Mar 19, 2018
Glaucoma, Ocular Hypertension Trial in Artesia, El Paso (Bimatoprost 0.01%, Bimatoprost 0.03%)
Completed
- Glaucoma
- Ocular Hypertension
- Bimatoprost 0.01%
- Bimatoprost 0.03%
-
Artesia, California
- +1 more
Apr 21, 2015
Glaucoma, Open-Angle, Ocular Hypertension Trial in United States (High Dose Device, Low Dose Device, Placebo Device)
Completed
- Glaucoma, Open-Angle
- Ocular Hypertension
- High Dose Device
- +2 more
-
Artesia, California
- +3 more
Feb 18, 2015
Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG286 Ophthalmic Solution 0.5%, AR-12286 Ophthalmic Solution
Completed
- Open Angle Glaucoma
- Ocular Hypertension
- PG286 Ophthalmic Solution 0.5%
- +2 more
-
Artesia, California
- +20 more
Feb 17, 2014
Primary Open-angle Glaucoma, Ocular Hypertension Trial in United States (OPA-6566, Placebo, Latanoprost)
Completed
- Primary Open-angle Glaucoma
- Ocular Hypertension
- OPA-6566
- +2 more
-
Artesia, California
- +8 more
Feb 7, 2014
Ocular Hypertension, Glaucoma Trial in Artesia (AGN-210669 ophthalmic solution, 0.075%, AGN-210669 ophthalmic solution, 0.05%,
Completed
- Ocular Hypertension
- Glaucoma
- AGN-210669 ophthalmic solution, 0.075%
- +4 more
-
Artesia, California(unnamed)
Aug 13, 2013
Glaucoma, Ocular Hypertension Trial in Worldwide (bimatoprost /timolol formulation A fixed combination ophthalmic solution,
Completed
- Glaucoma
- Ocular Hypertension
- bimatoprost /timolol formulation A fixed combination ophthalmic solution
- bimatoprost/timolol fixed combination ophthalmic solution
-
Artesia, California
- +8 more
Mar 22, 2013
Primary Open Angle Glaucoma, Ocular Hypertension Trial in United States (Stage 1 - ATS907 - Dose 1, Stage 1 - ATS907 - Dose 2,
Unknown status
- Primary Open Angle Glaucoma
- Ocular Hypertension
- Stage 1 - ATS907 - Dose 1
- +7 more
-
Artesia, California
- +4 more
Oct 30, 2012